首页> 外文期刊>Journal of Diabetes Science and Technology >System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method
【24h】

System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method

机译:根据葡萄糖氧化酶和基于己糖激酶的比较方法,按照ISO 15197的四个自我监测血糖系统的系统精度评估

获取原文
       

摘要

Background: The standard ISO (International Organization for Standardization) 15197 is widely accepted for the accuracy evaluation of systems for self-monitoring of blood glucose (SMBG). Accuracy evaluation was performed for 4 SMBG systems (Accu-Chek? Aviva, Contour?XT, GlucoCheck XL, GlucoMen? LX PLUS) with 3 test strip lots each. To investigate a possible impact of the comparison method on system accuracy data, 2 different established methods were used. Methods: The evaluation was performed in a standardized manner following test procedures described in ISO 15197:2003 (section 7.3). System accuracy was assessed by applying ISO 15197:2003 and in addition ISO 15197:2013 criteria (section 6.3.3). For each system, comparison measurements were performed with a glucose oxidase (YSI 2300 STAT Plus? glucose analyzer) and a hexokinase (cobas? c111) method. Results: All 4 systems fulfilled the accuracy requirements of ISO 15197:2003 with the tested lots. More stringent accuracy criteria of ISO 15197:2013 were fulfilled by 3 systems (Accu-Chek Aviva, ContourXT, GlucoMen LX PLUS) when compared to the manufacturer’s comparison method and by 2 systems (Accu-Chek Aviva, ContourXT) when compared to the alternative comparison method. All systems showed lot-to-lot variability to a certain degree; 2 systems (Accu-Chek Aviva, ContourXT), however, showed only minimal differences in relative bias between the 3 evaluated lots. Conclusions: In this study, all 4 systems complied with the evaluated test strip lots with accuracy criteria of ISO 15197:2003. Applying ISO 15197:2013 accuracy limits, differences in the accuracy of the tested systems were observed, also demonstrating that the applied comparison method/system and the lot-to-lot variability can have a decisive influence on accuracy data obtained for a SMBG system.
机译:背景技术:标准ISO(国际标准化组织)15197被广泛接受用于血糖自我监测(SMBG)系统的准确性评估。对4个SMBG系统(Accu-Chek?Aviva,Contour?XT,GlucoCheck XL,GlucoMen?LX PLUS)进行了准确性评估,每个批次有3个测试条。为了研究比较方法对系统精度数据的可能影响,使用了两种不同的已建立方法。方法:按照ISO 15197:2003(7.3节)中所述的测试程序,以标准化方式进行评估。系统精度通过应用ISO 15197:2003和ISO 15197:2013标准(第6.3.3节)进行评估。对于每个系统,使用葡萄糖氧化酶(YSI 2300 STAT Plus™葡萄糖分析仪)和己糖激酶(cobas®c111)方法进行比较测量。结果:所有4个系统的测试批次均满足ISO 15197:2003的精度要求。与制造商的比较方法相比,通过3个系统(Accu-Chek Aviva,ContourXT,GlucoMen LX PLUS)满足了更严格的ISO 15197:2013精度标准,而与替代系统相比,通过2个系统(Accu-Chek Aviva,ContourXT)满足了比较方法。所有系统在一定程度上显示了批次间的可变性。但是,2个系统(Accu-Chek Aviva,ContourXT)仅显示了3个评估批次之间相对偏差的最小差异。结论:在本研究中,所有4个系统均符合评估的试纸批,其准确度标准为ISO 15197:2003。应用ISO 15197:2013精度限制,可以观察到被测系统的精度差异,也表明所应用的比较方法/系统和批次间的可变性对SMBG系统获得的精度数据具有决定性影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号